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Background: Association between sleep disorders and headache is largely known. The aim of the present study
was to evaluate sleep quality and quantity in a large cohort of primary headache patients, in order to correlate
these scores with symptoms of central sensitization as allodynia, pericranial tenderness and comorbidity with
diffuse muscle-skeletal pain.
Methods: One thousand six hundreds and seventy primary headache out patients were submitted to the Medical
Outcomes Study (MOS) within a clinical assessment, consisting of evaluation of frequency of headache, pericranial
tenderness, allodynia and coexistence of fibromyalgia syndrome (FM).
Results: Ten groups of primary headache patients were individuated, including patients with episodic and chronic
migraine and tension type headache, mixed forms, cluster headache and other trigeminal autonomic cephalalgias.
Duration but not sleep disturbances score was correlated with symptoms of central sensitization as allodynia and
pericranial tenderness in primary headache patients. The association among allodynia, pericranial tenderness and
short sleep characterized chronic migraine more than any other primary headache form. Patients presenting with
FM comorbidity suffered from sleep disturbances in addition to reduction of sleep duration.
Conclusion: Self reported duration of sleep seems a useful index to be correlated with allodynia, pericranial
tenderness and chronic headache as a therapeutic target to be assessed in forthcoming studies aiming to prevent
central sensitization symptoms development.
Keywords: Sleep; Primary headaches; Central sensitization; FibromyalgiaBackground
A strong relationship between insomnia and painful dis-
orders has been reported [1], and studies indicate that
pain not only might be a risk factor for insomnia but that
the two disorders reciprocal influence and exacerbate each
other [2]. It is also likely that when insomnia and chronic
pain occur together their consequences are even more
devastating [2]. In clinical studies acute painful stimuli ap-
plied to healthy subjects during sleep resulted in transient
arousals [3], while chronic pain patients had poorer sleep
than controls in terms of sleep latency, sleep efficiency
and awakenings after sleep onset [4,5]. The existence of a
correlation and/or comorbidity between sleep disorders
and headache has been also largely demonstrated [6,7].* Correspondence: marina.detommaso@uniba.it
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reproduction in any medium, provided the origA recent review stated that sleep loss and sleep
deprivation have severe effects on human health, being a
risk factor for neurologic diseases, including headache [8].
Migraine attacks may be precipitated by sleep deprivation
or excessive sleep and sleep is also associated with relief of
migraine attacks. In previous studies, migraine attack was
found to be precipitated by sleep deprivation in 24% and
by sleep excess in 6% of cases [9]. The “lack of sleep” is
endorsed as a trigger among 48% to 74% of migraineurs
and 26% to 72% of tension-type headache sufferers, and
sleep disturbance has been consistently identified as a
headache trigger in retrospective studies [10,11]. The
effect of sleep in terminating an attack of headache is also
well known [7]. Kelman and Rains [6] assessed relations
between sleep and migraine and found that approximately
half of patients reported at least occasional symptoms of
insomnia, 38% reported sleeping less than 6 hours per
night, and 50% of patients reported that sleep disturbancehis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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of sleep problems increase proportionally to headache
frequency, such that the majority of chronic migraine
patients (68-84%) suffer from insomnia on a near-daily
basis [12-14]. Central sensitization is a phenomenon of
pain processing, which may predispose to chronic pain.
Allodynia occurring during migraine attack and persistent
pericranial tenderness in migraine and tension type head-
ache are symptoms of central sensitization [15,16], which
may be aggravated by sleep disturbances and/or exert a
negative impact on sleep in a mutual negative implication.
The comorbidity between primary headaches and fibro-
myalgia is also present in patients with accentuated
tendency to central sensitization [17-19]. Sleep deprivation
causes hyperalgesia in healthy volunteers [20], so the
relationship between sleep disturbances and symptoms
of central sensitization should be addressed in primary
headache in order to optimize their management.
The aim of the present study was to evaluate sleep
problems and duration in a large cohort of primary head-
ache patients, in order to correlate these parameters with
symptoms of central sensitization as allodynia, pericranial
tenderness and comorbidity with diffuse muscle-skeletal
pain. For this purpose the Medical Outcomes Study Sleep
Scale [21] was employed, which is a generic measure of
sleep problems that can be used to compare different clin-
ical populations to one another on a common metric. The
questionnaire is brief, responsive to change, and has been
used in FM [22]. In this study we didn’t evaluate a control
population, because our main interest was to correlate
sleep scores with clinical symptoms of central sensitization
in a large cohort of headache patients.
Methods
One thousand six hundreds and seventy out patients
were included in the present evaluation, among 2135
coming consecutively to the Neurophysiopathology of
Pain center of Bari University since 1/2012 to 12/2013.
Patients were included after three months from their
first approach to our Department, when a visit date was
assigned. Patients were invited to sign up their headache
and the possible presence of vegetative symptoms and
of allodynia, using a scale reporting the present of
nausea, vomiting, phonophobia and photophobia, and
the questionnaire reported by Ashkenazi et al. [23,24]
and previously applied in Italian version [17,18].
The diagnosis was made by 2 neurologists expert in
headache, in accord with the International Headache
Society criteria, on the basis of headache characteristics
and frequency in the three months preceding the visit
[25,26]. During the first visit, patients underwent the
clinical assessment, defined in previous studies [17,18],
consisting of evaluation of diaries reporting frequency of
headache, as the average number of days with headache/month, computed in the last three months, completed
by the report of pain features and vegetative symptoms
during single headache episodes. The allodynia ques-
tionnaire was also evaluated, which patients had been
requested to use for each headache episode [23,24]. The
presence of allodynia symptoms during the headache
episodes was inferred from the notes the patients made
on their diaries while answering the Italian version of
the questionnaire we had given them to complete after
each headache episode [24]. The most recent IHS criteria
[26] were directly applied to cases come in the last study
year, while previous diagnoses were updated by means of
a retrospective evaluation of headache characteristics
and frequency.
The inclusion criterion was the diagnosis of a primary
headache syndrome, according to the IHS criteria [25,26].
Patients with general medical and/or other neurological or
psychiatric diseases were excluded from the study, as well
as patients on central nervous system-active drug or pre-
ventive treatment for primary headache. Patients with a
diagnosis of “probable” primary headache were excluded.
We considered groups including at least 10 patients.
For cluster headache patients [22,23], only patients with
chronic form or during cluster episode were included.
Patients were classified as allodynic if they confirmed
the presence of at least one symptom reported in the
questionnaire, for 50% or more of the headache episodes.
For each patient a mean allodynia score was also com-
puted. Total tenderness score (TTS) was also evaluated in
all patients to evaluate pericranial tenderness, following
the procedure described by Langermark and Olesen
[27]. Assessment was performed with manual palpation
by a neurologist with experience in headache, who was
experimentally blinded to the patient’s diagnosis. The
right frontal muscle, masseter muscle, temporal muscle,
pterigoid muscle, sternocleidomastoid muscle, sterno-
cleidomastoid muscle insertion, neck muscle insertion
and trapezium muscle were examined using the TTS
system. Patients were submitted to the depression [self-
rating depression scale (SDS)] and anxiety. [Self-rating
anxiety scale (SAS)] scales, as they are considered reliable
tools to detect symptoms of anxiety and depression in
a general non-psychiatric patient population [28,29].
According to previous studies [17] we applied the Italian
version of the MIDAS score to all type of headaches
[30,31], to quantify headache-related disability.
In order to assess the presence of fibromyalgia comor-
bidity, patients underwent the most recent diagnostic
criteria [32], together with fibromyalgia impact profile
(FIQ) [33] and tender point count [34]. The Fibromyalgia
Impact Questionnaire (FIQ) is a fibromyalgia-specific
patient-reported outcome Instrument designed to assess
health status, progress and outcomes in patients with
fibromyalgia. It contains 10 subscales that are combined
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Survey (MTPS) provided a rate of the severity of pain
patients felt upon palpation of the specific 18 tender
points defined by the American College of Rheumatology
and of three control sites [34]. In all patients the Medical
Outcomes Study (MOS) [21] was applied, which is a
12-item self report questionnaire that measures six
dimensions of sleep, including initiation, maintenance
(e.g. staying asleep), quantity, adequacy, somnolence (e.g.
drowsiness), and respiratory impairments (e.g. shortness
of breath, snoring, in a total of eight parameters. It has
been previously applied in patients with chronic pain [19]
and primary headache [14,15]. Each scale (except sleep
quantity) is recalibrated onto a 0–100 scale. For most
scales, higher scores indicate worse sleep problems. For
sleep quantity (SLPQRAW) lower scores indicate worse
sleep problems, referring to hours of sleep for night in
the last week. The MOS Sleep Scale can be aggregated
to produce 2 summary indices, the Sleep Problems Index
II (9 items) and the Sleep Problems Index I (six items).
Each of these indices integrates the domains of sleep
disturbance, sleep adequacy, shortness of breath, and
somnolence into a single score. The difference between
Sleep Problems Index 1 and 2 is simply length rather
than domain coverage; potentially overlapping items
were eliminated in Index 1, which seems a reliable and
simple global sleep problems score. Higher scores on
either index are indicative of worse sleep problems. In
this study we choose to report results obtained by sleep
quantity (SLPQRAW) and Sleep Problems Index 1 (SLP6),
while the results of the other items were reported in the
Additional file 1.
The study was approved by the Bari Policlinico General
Hospital ethical committee, and each patient signed an
informed consent.Statistical analysis
The multivariate ANOVA was applied considering the
parameters SLPQRAW (sleep quantity -raw) and SLP6
(sleep problems index I), allodynia and pericranial ten-
derness as variables and the type of headache as factors.
The Bonferroni was employed as post-hoc test, to com-
pare the MOS SLPQRAW and SLP6 items, allodynia
and pericranial tenderness between the single headache
groups. Results obtained by the comparison of the
other MOS items were reported in the Additional file 1.
The presence of allodynia in headache groups was
further compared by means of chi-square test, and the
SLPQRAW and SLP6 items compared between allody-
nic and not allodynic patients by means of multivariate
ANOVA. Patient was considered allodynic when reporting
at least one symptom in more than 50% of headache
episodes.The Pearson correlation test was also employed to
correlate the MOS items with allodynia and pericranial
tenderness in the total of patients and single primary
headache groups including at least 100 cases. In this
correlation, we included also the anxiety and depression
scores. For the high number of correlations, we considered
only Pearson values with a level of significance <0.01.
Correlation analysis regarding the other MOS items
was reported in Additional file 1.
A multivariate ANOVA was also employed considering
the two MOS SLPQRAW and SLP6 parameters as vari-
ables and the presence of fibromyalgia diagnosis as factor.
The Pearson correlation test was also employed to test
correlations among MOS items and fibromyalgia impact
questionnaire and pain at tender points. Statistic was com-
puted by IBM SPSS vers 21. For MANOVA tests, age was
introduced as correcting factor and sex as a covariate.
Results
Ten groups of primary headache patients were individu-
ated, which demographic and clinic characteristics are
detailed in Table 1. The primary forms with fewer than 10
cases were included in a single group as “other primary
headaches”, which was quite heterogeneous (Table 1).
The MANOVA analysis indicated that the SLPQRAW
(sleep quantity -raw) was significantly different (F = 5.87
DF 9 p < 0.0001), while the SLP6 index was similar.
(F = 0.93 DF 9 n.s.), among headache groups. The
Bonferroni test showed that chronic migraine reported
fewer sleep time compared to episodic migraine with-
out aura, episodic tension type headache and the groups
associating migraine without aura plus migraine with aura
and tension type headache (Table 1, Figure 1). The other
MOS scores were not significantly different among pri-
mary headache groups (see Additional file 1). Sex did not
influence sleep scores (SLPQRAW F = 3.28 DF 1 n.s.;
SLP6 F = 1.55 DF 2 n.s.).
Allodynia scores were significantly different among
headache groups (F 5.13 DF 9 p <0.0001), for lower values
in other primary headaches compared to other groups,
excluding tension type headache, and significant higher
scores in chronic migraine compared to chronic and
episodic tension type headache. Episodic tension type head-
ache displayed reduced scores of allodynia also in compari-
son with migraine without aura (Table 1, Figure 2).
Pericranial tenderness scores were also significantly
different among headache groups (F = 8.82 DF 9 p < 0.0001),
being higher in chronic migraine compared to other
headaches, excluding chronic tension type headache.
(Table 1, Figure 2). Sex significantly influenced both
allodynia and TTS scores, for higher values in females
(allodynia F = 13.49 DF 1 p < 0.0001; TTS F = 7.97 p 0.005).
The presence of allodynia varied from the 56.4% in the
group of other primary headaches to the 91% in chronic
Table 1 Demographic and clinical features of primary headache patients















Migraine without aura 1.1 175 M 37.09 16.23 6.45 30.16 4.97 3.18 49.14 6.67
625 F 12.21 11.75 5.32 36.61 5.74 2.16 24.91 1.5
Migraine with aura 1.2.1 11 M 35.87 12.97 2.32 13 3.47 2.38 43.44 7.07
27 F 12.15 10.15 2.68 21.33 4.98 2.62 29.09 1.17
Migraine Without aura 1.1 plusEpisodic tension type headache 2.2 24 M 38.56 16.28 6.2 25.16 4.92 3.36 53.54 6.83
78 F 13.21 11.41 5.8 32.14 4.8 2.27 24.30 1.83
Migraine without aura 1.1. plus migraine with aura 1.2.1 10 M 35.98 17.15 5,34 28 5.64 3.36 50.58 7.04
57 F 10.67 10.2 5 27.19 5 2.35 22.35 1.53
Chronic Migraine 1.3 53 M 41.34 18.9 23.52 61.47 7.84 3.62 52.46 6.1
280 F 14.4 13.7 6.5 47.3 6 2.34 21.67 1.63* + ^°
Episodic tension type headache 2.2 35 M 40.64 12.28 6.12 16.50 4.66 2.55 52.1 6.86
76 F 16.64 12.46 4.12 25.11 4.37 2 22.3 1.76
Chronic tension type headache 2.3 44 M 43 12.77 24,19 45.13 6 2.48 50.28 6.31
89 F 14.98 13.33 6.45 53.03 5.66 2.28 23.33 1.67
Other TACs (Paroxysmal hemicranias 3.2, n° 8; Hemicrania continua,
3.4 n° 9)
4 M 43.29 13.73 26.22 38.47 3.67 3.71 43.80 6.73
13 F 16.13 14.42 9.3 39.25 3.81 2.73 25.58 2.27
Cluster headache 3.1 (3.1.1 episodic cluster headache, n° 18;
3.1.2 chronic cluster headache, n° 10)
21 M 39.21 14 11.6 27 2.43 2.74 52.5 5.95
7 F 11.52 11.5 14.5 35.34 3.02 2.45 23,48 2.05
Other primary headaches (Primary exercise headache 4.2, n° 5; Primary
headache associated with sexual activity 4.3, n° 3; Primary thunderclap
headache 4.4, n° 4; Primary stabbing headache 4.7, n° 9; Nummular
headache 4.8, n° 7; Hypnic headache 4.9, n° 5)
14 M 41.71 11.86 14.11 22.9 2.96 1.4 54.37 6.45
27 F 15.94 12.7 12.13 39.9 3.2 1.6 24.47 1.27
SLPQRAW (Sleep quantity -raw); SLP6: Sleep problems index I.
The IHS classification code is specified for each headache group and type. The results of Bonferroni test are shown: Chronic migraine vs * migraine without aura, + migraine without aura plus episodic tension type






















Figure 1 Mean values and standard errors of SLPQRAW (sleep quantity -raw) and SLP6 (sleep problems index 1) in primary headache
groups. The symbol * indicate the results of Bonferroni test: chronic migraine compared to migraine with and without aura, other TACs, migraine
without aura plus episodic tension type headache, and chronic and episodic tension type headache: p < 0.05.
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item was similar in allodynic and not allodynic patients
(F = 1.94 n.s.), while the SLPQRAW score was signi-
ficantly lower in allodynic patients (F = 4.5 p 0.039)
(Figure 3).
The SLPQRAW was significantly correlated with all
clinical features, including disease duration, allodynia,
TTS, SAS and SDS (Table 2), while the SPL6 index was
not correlated to headache frequency or symptoms of
central sensitization, showing a significant correlation
with anxiety. Allodynia and pericranial tenderness were
also significantly correlated with anxiety and depression
scores, as well as with invalidity linked with headache in
the total and single headache groups (Table 3). The same
correlations were also present in chronic migraine group,
while in episodic migraine without aura and chronic ten-
sion type, the total time of sleep was inversed correlated
with pericranial tenderness (Table 3). The other MOS
scores were not correlated with allodynia and pericranial
tenderness (See Additional file 1).
Fibromyalgia was diagnosed in the 17, 54% of primary
headache patients. The percent number of FM patients
for single headache groups is reported in Figure 4. The
frequency of FM ranged from 32, 33% in chronic tension
type headache, to 0% in cluster headache (chi square
104.12 DF 9 p 0.00001).
The MANOVA showed that the SLPQRAW MOS
score was significantly different between patients with
and without FM symptoms (39.15 DF 1 p <0.0001).Sleep problems, expressed by the SLP6 index, were also
slightly increased in patients presenting with FM comor-
bidity (F 4.1 DF 1 p 0.047) (Figure 4).
Fibromyalgia severity, measured by FIQ score [22] was
also correlated with short sleep time and increased sleep
problems (Pearson correlation: FIQ vs SLPQRAW −0.332
p < 0.01; vs SLP6 0.282 p < 0.01). Pain at tender point was
not correlated with MOS items.
Discussion
Our study tested sleep features and central sensitization
symptoms in a large cohort of primary headache patients
including patients with TACs and other mixed forms. The
results of this study showed that sleep quantity was signifi-
cantly reduced in primary headache patients reporting
symptoms of central sensitization, as allodynia during
headache episodes and pericranial tenderness. Chronic
migraine was the headache group reporting more severe
allodynia in respect to other headache groups, in accord
with first descriptions of allodynia development during
migraine attack [16] as a predictor of increasing frequency
of migraine days [35]. However, allodynia was largely
represented in chronic tension type headache and cluster
headache groups, while a smaller part of the mixed pri-
mary headache group reported those symptoms. Current
theories attribute to central sensitization an important
role in tension type headache pathogenesis [36-38] with
evidence of allodynia symptoms in chronic forms [38],
as confirmed by present results. In regard to cluster
Figure 2 Top: Mean values and standard errors of allodynia scores in primary headache groups. The symbols *, ° and + indicate the
results of Bonferroni test: * chronic migraine compared to migraine with and without aura, other TACs, migraine without aura plus episodic
tension type headache, chronic and episodic tension type headache: * p < 0.05; ° other primary headaches compared to all the remaining groups:
p < 0.05; + episodic tension type headache vs migraine without aura: p < 0.05. Bottom: Mean values and standard errors of pericranial tenderness
scores in primary headache groups. The symbol * indicates the results of Bonferroni test: * chronic migraine compared to other primary
headache groups, excluding chronic tension type headache: p < 0.05.
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cluster episodes, in accord with present results [39],
while this is the first study suggesting the presence of
allodynia in other TACs, as paroxysmal migraine and
hemicranias continua. Actually we cannot advance
conclusions on reduced expression of allodynia in the
mixed headaches group, which was a very heterogeneous
group and worthy of further case series enlargement,
considering the importance of a better knowledge of
these rare disorders. Unfortunately, cases of hyping
headache were also few, deserving further consideration
in a larger group. Pericranial tenderness was also more
expressed in chronic migraine compared to other head-
ache groups, excluding chronic tension type headache.
This confirmed the relation between pericranial pain
and chronic tension type headache and migraine [15]
but suggested the scarce presence of this symptom in
TACs and other primary headache forms. Quantity
more than other sleep problems seemed to be critical for
central sensitization symptoms severity in our headache
series, with a strong correlation with both allodynia and
pericranial tenderness. Gender was a critical factor for
both allodynia and pericranial tenderness, but not forsleep features, according to complex hormonal influences
on pain processing and chronic syndromes [40] Primary
headaches may lead to sleep reduction in both males
and females, with pronounced expression of central
sensitization symptoms in the latter group. However,
the influence of sex on primary headaches phenotype
including symptoms of central sensitization is very
complex and deserves specific examination in further
studies. Chronic migraine patients presented with reduced
sleep quantity compared to episodic migraine and tension
type headache, confirming the strict relation between
short sleep time, central sensitization symptoms and
chronic pain development. The MOS questionnaire tests
six dimensions of sleep, including initiation, maintenance
(e.g. staying asleep), quantity, adequacy, somnolence (e.g.
drowsiness), and respiratory impairments (e.g. shortness
of breath, snoring). We choose to examine only the SLP6
index, which is a summary of sleep problems based on
adequacy, shortness of breath, and somnolence [21].
Moreover, the other MOS scores testing sleep problems
did not show relevant results from statistical comparison
among headache groups and correlation with symptoms
of central sensitization. In a study by Lovati et al. [41],
Figure 3 Top: Percent rates of primary headache patients presenting with allodynia. Bottom: Mean ± SE SLPQRAW (sleep quantity -raw) and SLP6
(sleep problems index 1) scores in primary headache patients presenting and not presenting with allodynia. Results of MANOVA are shown: * p < 0.05.
Table 2 Pearson correlation analysis among MOS items and main clinical features in the total of primary headache
patients and main subgroups
SLPQRAW SLPQRAW SLP6 DURATION FREQUENCY MIDAS ALLODYNIA TTS SAS SDS
All (n°1670) 1 0.019 −0.180** −0.144** −0.141** −0.085** −0.117** −0.208** −0.233**
Migraine (1.1) (n° 800) 1 0.001 −0.164** −0.079* −0.083* −0.043* −0.185** −0.185** −0.213**
Migraine (1.2 and 1.2 plus1.1) (n°105) 1 0.002 −0-060 −0.121 −0.111 −0.110 −0.210* −0.112 −0.154
Chronic Migraine 1.3 (n°333) 1 0.046 −0.136* −0.274** −0.287** −0.332** −0.321** −0.312** −0.356**
Chronic tension type headache 2.3
(n°133)
1 0.034 −0,193 −0.189 −0.234* −0.122 −0.238** −0.125 −0.259**
Episodic tension type headache 2.2
(n°111)
1 0.023 −0,211* −0.123 0.145 0.167 0.145 0.176 −0.258**
SLP6
All (n°1670) 0.019 1 0.09 0.047 0.028 0.010 0.055 0.087** 0.060
Migraine (1.1) (n° 800) 0.001 1 0.087 0.029 0.021 0.008 0.045 0.099 0.097
Migraine (1.2 and 1.2 plus1.1) (n°105) 0.004 1 0.121 0.023 0.012 0.005 0.034 0.134 0.135
Chronic Migraine 1.3 (n°333) 0.023 1 0.097 0.123 0.121 0.034 0.045 0.145* 0.090
Chronic tension type headache2.3 (n°133) 0.189 1 0.081 0.034 0.089 0.076 0.029 0.089 0.129
Episodic tension type headache 2.3
(n°111)
0.056 1 0.101 0.89 0.034 0.109 0.115 0.178 0.276
The IHS specification code is indicated: 1.1 migraine without aura; 1.2 migraine with aura; 1.3 chronic migraine; 2.3 chronic tension type headache; 2.2 episodic
tension type headache.
The significant results are outlined in bold character. **p < 0.01. The p values < 0.05 are indicated by the symbol *, but not outlined.
SLPQRAW: Sleep quantity raw score.
SLP6: Sleep index 1.
TTS Total Tenderness Score.
SAS: Self rating Anxiety Scale.
SDS: Self rating Depression Scale.
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Table 3 Pearson correlation analysis among central sensitization symptoms and other clinical features in the total of
primary headache patients and main subgroups
ALLODYNIA FREQUENCY MIDAS ALLODYNIA TTS SAS SDS
All (n°1670) 0.085* 0.296** 1 0.228** 0.296** 0.292**
Migraine (1.1) (n° 800) 0,103** 0.213** 1 0.133** 0.274** 0.207**
Migraine (1.2 and 1.2 plus1.1) (n°105) 0.204* 0.223* 1 0.225* 0.284** 0.374**
Chronic Migraine 1.3 (n°333) 0.321** 0.345** 1 0.367** 0.267** 0.336**
Chronic tension type headache2.3 (n°133) 0.09 0.187* 1 0.289** 0.334** 0.310**
Episodic tension type headache 2.2 (n°111) 0,118 0,400** 1 0.280** 0.334** 0.362**
TTS
All (n°1670) 0.199** 0.188** 0.228** 1 0.251** 0.216**
Migraine (1.1) (n° 800) 0.219** 0.213** 0.133** 1 0.203** 0.232**
Migraine (1.2 and 1.2 plus1.1) (n°105) 0.242* 0.326** 0.225* 1 0.292*° 0.327**
Chronic Migraine 1.3 (n°333) 0.180** 0.226** 0.367** 1 0.270*° 0.227**
Chronic tension type headache2.3 (n°133) 0.180* 0.226** 0.289** 1 0.269*° 0.228**
Episodic tension type headache 2.2 (n°111) 0,253* 0.133 0.280** 1 0.245* 0.362**
The IHS specification code is indicated: 1.1 migraine without aura; 1.2 migraine with aura; 1.3 chronic migraine; 2.3 chronic tension type headache; 2.2 episodic
tension type headache.
The significant results are outlined in bold. **p < 0.01. The p values < 0.05 are indicated by the symbol *, but not outlined.
TTS Total Tenderness Score.
SAS: Self rating Anxiety Scale.
SDS: Self rating Depression Scale.
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during sleep, reported also high scores of allodynia. In
light of present results, the increase of central sensitization
symptoms could be related to the sleep deprivation in-
duced by respiratory dysfunction. Angstrom et al. [42]Figure 4 Top: Percent rates of primary headache patients presenting
quantity -raw) and SLP6 (sleep problems index 1) scores in primary headac
MANOVA are shown: *p < 0.05, ****p < 0.00001.found EEG signs of sleep deprivation in tension type head-
ache and migraine patients, despite normal sleep times
in diary. They concluded that headache patients need
on average more sleep than healthy controls, and that
inadequate rest might be an attack-precipitating- andwith Fibromyalgia syndrome. Bottom: Mean ± SE of SLPQRAW (sleep
he patients presenting and not presenting with allodynia. Results of
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the sleep time was on average 6.7 hours in non allodynic
and 6 hours in allodynic patients, which was below the
limit of optimal sleep in accord with MOS score [43],
actually speculative and worthy of confirmation in a
control group. Sleep deprivation causes hyperalgesia in
normal controls [20], while further case- control studies
may clarify if the sleep time threshold for central
sensitization symptoms development may be lower in
primary headache in respect to controls. Moreover, the
reasons for sleep time reduction are numerous in primary
headaches, as showed by the correlation between short
sleep time and headache frequency and severity, as well
as anxiety and depression, though some significant cor-
relations were due to the high number of subjects and not
present in all primary headache groups. Sleep duration
and headache frequency and invalidity were inversely
correlated in chronic migraine patients, which included
patients affected by more severe central sensitization
symptoms and sleep deprivation. High frequency of
headache may cause sleep disruption for unexpected
night or early morning arousing, as well as for troubling
in falling asleep, while “lack of sleep” is a trigger among
the majority of migraineurs and tension-type headache
sufferers [10,11]. Headache severity and invalidity, as
tested by MIDAS, may further deteriorate sleep for the
worries coming from social and familiar problems caused
by high headache frequency. Psychopathological traits as
anxiety and depression are well known factors of sleep
reduction [44]. The SLPQRW score was also reduced in
patients with long disease duration, probably because
headache and especially migraine persistence may aggra-
vate this aspect of sleep. In chronic migraine group, this
correlation did not reach the statistic significance, as sleep
deprivation may be intrinsic to this chronic syndrome
just in the early phase. Headache severity, anxiety and
depression were correlated with allodynia and pericranial
tenderness in the total and single headache groups, also
in accord to previous studies [45]. Moreover, chronic
migraine and chronic tension type headache showed a
relationship between short sleep duration and increased
expression of central sensitization symptoms as pericranial
tenderness, suggesting a reverberating mechanism where
headache frequency, low pain threshold, reduced sleeps
time and psychopathological factors interfere in a complex
way in generating chronic syndromes [14]. In this sense,
chronic migraine is caused by a critical convergence of
these factors [12,14]. The management of headache could
take into account therapeutic substances acting on patho-
physiological mechanism of both sleep and pain [46] as
well as behavioral non pharmacological approach to sleep
modification [47].
A complex dysfunction in orexins transmission may
also explain the correspondence between lack of sleepand altered modulation of pain with central sensitization
facilitation. Chronic pain lead to sleep disturbance in
parallel with changes in circadian rhythm for mRNA
expression of orexin receptors in animal models of
hypothalamus [48], while the analgesic role of orexins is
currently recognized on the basis of the experimentally
induced inhibition of nociceptive transmission via spinal
orexin receptors activation [49].
The total score of sleep problems, as tested by the
SLP6 index, did not show the same performance as the
raw score of sleep duration in differentiating patients
with signs of central sensitization. The reason may be a
specific effect of sleep deprivation on mechanisms of
central sensitization, as suggested by studies on healthy
volunteers [20]. However, specific sleep disturbances
may be present in primary headaches, as reported in
previous studies, where patients with chronic headache
showed a high prevalence of daytime sleepiness and
snoring with respect to controls [14]. The SLPQWR score,
with the limitation due to a subjective report, seems a
useful index to be evaluated in view of correlation with
symptoms of central sensitization.
Fibromyalgia comorbidity is a quite frequent cause of
comorbidity in primary headache patients, characterizing
more severe and invalidating forms. [17,18]. The present
study confirms a high representation of FM syndrome in
chronic tension type headache and chronic migraine and
a rare presence in patients with TACs, migraine with
aura and other primary headaches types [18].
In accord with sleep disorder as part of FM diagnosis
[32,50], we found that headache patients with FM comor-
bidity presented with increased sleep disturbances and
deprivation, which were both correlated with invalidity
due to symptoms of diffuse pain. Present results may thus
suggest that sleep problems other than raw sleep quantity
are critical for FM comorbidity in primary headaches,
while shortness of sleep alone prevails in allodynic not
fibromyalgic headache patients. Nevertheless in FM
patients, the lack of a linear correlation between sleep
disturbances and somatic hyperalgesia may be due to the
complex physiopathology of this syndrome, presently under
careful revision for a possible involvement of peripheral
afferents dysfunction [51].
Conclusions
Summarizing, our study confirms that duration of sleep
is associated to symptoms of central sensitization as
allodynia and pericranial tenderness in primary headache
patients. The association among allodynia, pericranial
tenderness and short sleep characterizes chronic migraine
more than any other primary headache form. Patients
presenting with FM comorbidity suffer from a global
impairment of sleep. Self reported duration of sleep seems
a useful index to be correlated with allodynia, pericranial
de Tommaso et al. The Journal of Headache and Pain 2014, 15:64 Page 10 of 11
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to be assessed in future prospective studies aiming to
prevent central sensitization symptoms development.
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